Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enzalutamide (xtandi) (1 trial)
for46 (3 trials)
Multiple Myeloma (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Prostatic Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (2 total)